An integrin-targeted non-viral vector for pulmonary gene therapy
- PMID: 10694821
- DOI: 10.1038/sj.gt.3301095
An integrin-targeted non-viral vector for pulmonary gene therapy
Abstract
Gene therapy offers potential for the treatment of severe respiratory diseases. However, the vectors which are currently available have drawbacks limiting their therapeutic application. Here we report on an integrin-targeted, non-viral gene delivery system for pulmonary gene transfer. We demonstrate that this vector can deliver the lacZ reporter gene to the lung, transfecting bronchial epithelium and parenchymal cells with similar efficiency to an adenoviral vector and with greater efficiency than a cationic liposome. In addition, vector administration can be repeated leading to further gene expression without inducing inflammation. The advantages of this novel gene delivery system provide considerable potential for targeted gene therapy in vivo. Gene Therapy (2000) 7, 393-400.
Similar articles
-
A novel approach for gene therapy: engraftment of fibroblasts containing the artificial chromosome expression system at the site of inflammation.J Gene Med. 2006 Jan;8(1):63-71. doi: 10.1002/jgm.810. J Gene Med. 2006. PMID: 16038012
-
Atrial natriuretic peptide gene transfection with a novel envelope vector system ameliorates pulmonary hypertension in rats.J Thorac Cardiovasc Surg. 2008 Jul;136(1):142-9. doi: 10.1016/j.jtcvs.2007.10.061. Epub 2008 May 12. J Thorac Cardiovasc Surg. 2008. PMID: 18603067
-
Liposome mediated in vivo gene transfer into different tissues of the gastrointestinal tract.Z Gastroenterol. 1994 Dec;32(12):665-70. Z Gastroenterol. 1994. PMID: 7871855
-
Integrin-mediated vectors for gene transfer and therapy.Curr Opin Mol Ther. 1999 Apr;1(2):197-203. Curr Opin Mol Ther. 1999. PMID: 11715943 Review.
-
Targeted gene delivery to the lung.Expert Opin Drug Deliv. 2009 Jun;6(6):567-83. doi: 10.1517/17425240902927841. Expert Opin Drug Deliv. 2009. PMID: 19450167 Review.
Cited by
-
The nuclear pore complex: the gateway to successful nonviral gene delivery.Pharm Res. 2006 Mar;23(3):447-59. doi: 10.1007/s11095-005-9445-4. Epub 2006 Mar 15. Pharm Res. 2006. PMID: 16525863 Review.
-
Adenine base editing of CFTR using receptor targeted nanoparticles restores function to G542X cystic fibrosis airway epithelial cells.Cell Mol Life Sci. 2025 Apr 7;82(1):144. doi: 10.1007/s00018-025-05587-y. Cell Mol Life Sci. 2025. PMID: 40192756 Free PMC article.
-
Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene.World J Gastroenterol. 2002 Apr;8(2):270-5. doi: 10.3748/wjg.v8.i2.270. World J Gastroenterol. 2002. PMID: 11925606 Free PMC article.
-
DNA as therapeutics; an update.Indian J Pharm Sci. 2009 Sep;71(5):488-98. doi: 10.4103/0250-474X.58169. Indian J Pharm Sci. 2009. PMID: 20502565 Free PMC article.
-
Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium.PLoS One. 2011;6(10):e26768. doi: 10.1371/journal.pone.0026768. Epub 2011 Oct 26. PLoS One. 2011. PMID: 22046351 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical